(Q33830439)

29 July 2017

1 reference

title

Managing pediatric atopic dermatitis (English)

1 reference

29 July 2017

S S Raimer

1

1 reference

29 July 2017

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

39

1 reference

29 July 2017

1

1 reference

29 July 2017

1-14

1 reference

Atopic dermatitis: an increasing problem

29 July 2017

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

The prevalence of childhood atopic eczema in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

Genetic risk for asthma, allergic rhinitis, and atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

Eczema herpeticum. Clinical and laboratory features

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

Disease management of atopic dermatitis: a practice parameter. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Counci

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

Atopic dermatitis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

Fluticasone propionate 0.05% cream in the treatment of atopic eczema: a multicentre study comparing once-daily treatment and once-daily vehicle cream application versus twice-daily treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

Food hypersensitivity and atopic dermatitis: evaluation of 113 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

Fel d I allergen distribution in cat fur and skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

The major dog allergens, Can f 1 and Can f 2, are salivary lipocalin proteins: cloning and immunological characterization of the recombinant forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

Anxiety, depression and psychosomatic symptoms in patients with atopic dermatitis: comparison with normal controls and among groups of different degrees of severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

Psychotherapy for intractable inflammatory dermatoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

21 January 2018

Phototherapy of eczema

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

Cyclosporine in severe childhood atopic dermatitis: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

Development and validation of a quality of life instrument for cutaneous diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

Dermatology in-patient management greatly improves life quality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

What do members of the National Eczema Society really want?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

Atopic eczema: its impact on the family and financial cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280003900101

10.1177/000992280003900101

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10660813